NBP
Price:
$3.99
Market Cap:
$3.25B
NovaBridge Biosciences, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the treatment of gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, a bispecific antibody, which is in phase 1 clinical trial for the treatment of solid tumors. It has a strategic licensing agreement with Ferring International Center SA to research, develop, make, have made, import, use, sell, and offer to sell FE301, an interleukin-6 inhibitor. The company also has collaborations with Bristol Myers Squibb for the development...[Read more]
Industry
Biotechnology
IPO Date
2020-01-17
Stock Exchange
NASDAQ
Ticker
NBP
According to NovaBridge Biosciences’s latest financial reports and current stock price. The company's current Current Ratio is 22.82. This represents a change of 11.23% compared to the average of 20.51 of the last 4 quarters.
The mean historical Current Ratio of NovaBridge Biosciences over the last ten years is 7.59. The current 22.82 Current Ratio has changed 29.95% with respect to the historical average. Over the past ten years (40 quarters), NBP's Current Ratio was at its highest in in the June 2025 quarter at 22.82. The Current Ratio was at its lowest in in the March 2018 quarter at 0.
Average
7.59
Median
5.78
Minimum
2.31
Maximum
20.90
Discovering the peaks and valleys of NovaBridge Biosciences Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 300.95%
Maximum Annual Current Ratio = 20.90
Minimum Annual Increase = -60.69%
Minimum Annual Current Ratio = 2.31
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 20.90 | 268.35% |
| 2023 | 5.67 | 3.23% |
| 2022 | 5.50 | -28.27% |
| 2021 | 7.66 | -17.38% |
| 2020 | 9.28 | 300.95% |
| 2019 | 2.31 | -60.69% |
| 2018 | 5.88 | 66.03% |
The current Current Ratio of NovaBridge Biosciences (NBP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
10.69
5-year avg
9.80
10-year avg
7.59
NovaBridge Biosciences’s Current Ratio is greater than Galectin Therapeutics Inc. (0.09), less than Design Therapeutics, Inc. (25.13), greater than DiaMedica Therapeutics Inc. (7.55), greater than Aura Biosciences, Inc. (12.39), greater than Rocket Pharmaceuticals, Inc. (7.30), greater than Annexon, Inc. (5.67), greater than Alpha Tau Medical Ltd. (8.43), greater than LB Pharmaceuticals Inc Common Stock (3.56), greater than enGene Holdings Inc. (10.34), greater than Altimmune, Inc. (17.18),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.09 | $405.63M | |
| 25.13 | $559.35M | |
| 7.55 | $449.43M | |
| 12.39 | $409.59M | |
| 7.30 | $370.12M | |
| 5.67 | $536.98M | |
| 8.43 | $346.14M | |
| 3.56 | $487.01M | |
| 10.34 | $420.82M | |
| 17.18 | $468.65M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NovaBridge Biosciences using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NovaBridge Biosciences or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is NovaBridge Biosciences's Current Ratio?
How is the Current Ratio calculated for NovaBridge Biosciences (NBP)?
What is the highest Current Ratio for NovaBridge Biosciences (NBP)?
What is the 3-year average Current Ratio for NovaBridge Biosciences (NBP)?
What is the 5-year average Current Ratio for NovaBridge Biosciences (NBP)?
How does the current Current Ratio for NovaBridge Biosciences (NBP) compare to its historical average?